Drug Patent Expirations in January 2012
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
|---|---|---|---|---|
| VITRASERT | Bausch And Lomb | ganciclovir | 5,378,475 | Jan 3, 2012 |
| LUNESTA | Sunovion Pharms Inc | eszopiclone | 6,319,926 | Jan 16, 2012 |
| LUNESTA | Sunovion Pharms Inc | eszopiclone | 7,381,724 | Jan 16, 2012 |
| PREFEST | Teva Womens | estradiol; norgestimate | 5,382,573 | Jan 17, 2012 |
| VIDEX | Bristol Myers Squibb | didanosine | 5,880,106*PED | Jan 22, 2012 |
| OCTREOSCAN | Mallinckrodt | indium in-111 pentetreotide kit | 5,384,113 | Jan 24, 2012 |
| TASMAR | Valeant Pharm Intl | tolcapone | 5,236,952 | Jan 29, 2012 |
| PROTOPIC | Astellas | tacrolimus | 5,385,907 | Jan 31, 2012 |
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.
Courtesy of DrugPatentWatch.com
![[Facebook]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/facebook.png)
![[Google]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/google.png)
![[LinkedIn]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Twitter]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/twitter.png)
![[Email]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/email.png)
